Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation (SEM)
Comparison of the Efficacy and Safety of Sirolimus, Everolimus or Mycophenolate in Renal Transplant Recipients Receiving Induction With Anti-thymocyte Globulin, Tacrolimus and Prednisone
Sponsor: Hospital do Rim e Hipertensão
A PHASE4 clinical study on Kidney Transplant Infection, this trial is completed. The trial is conducted by Hospital do Rim e Hipertensão and has accumulated 9 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
May 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Sep 2021 — May 2023 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Mar 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
▶ Show 4 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE4
-
Sep 2019 — Jan 2021 [monthly]
Recruiting PHASE4
-
Jun 2018 — Sep 2019 [monthly]
Recruiting PHASE4
-
Apr 2018 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Jun 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hospital do Rim e Hipertensão
For direct contact, visit the study record on ClinicalTrials.gov .